In the TRACERx study, multi-region whole-exome sequencing on 100 early-stage NSCLC tumours revealed 7 KRAS G12C-positive tumours, with one tumour harbouring co-occurring KRAS G12C and G12V mutations. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.